Spark Therapeutics Prices First-Ever Gene Therapy At $850,000 … – Investor’s Business Daily
Investor’s Business Daily |
Spark Therapeutics Prices First-Ever Gene Therapy At $850,000 …
Investor’s Business Daily Spark and GlaxoSmithKline are pricing the world's first approved gene therapies at prices approaching $1 million. |
